Information Library
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Accessing the Business Impact of Comparative Effectiveness
November 9, 2009
The increasing use of comparative effectiveness research practices such as Health Technology Assessment (HTA) is emerging as one of the policy issues that could have a significant effect on every link in the product development chain. -
Hepatitis B Vaccine-Successful Study Strategy in Asia
November 9, 2009
Quintiles helped a customer overcome recruitment and regulatory challenges for a Hepatitis B vaccine study in Asia. -
QUINTILES OPENS EXPANDED ASIA-PACIFIC HEADQUARTERS IN SINGAPORE
November 6, 2009 - To meet the growing demand for its services throughout the Asia-Pacific region, Quintiles announced the official grand opening of its expanded Asia-Pacific regional headquarters facility in Singapore's Science Park I. -
Evaluating Central Nervous System Drug Labels for Patient-Reported Outcomes Claims
November 4, 2009
Shilpa Viswanathan, International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting -
Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihyperten
November 4, 2009
Murtuza Burhmal, Associate Director of Medical Affairs for Epidemiology and Outcomes Research, Health and Quality of Life Outcomes 2009 -
Practical Guidance for Observational Research
November 4, 2009
Angela Vinken, Vienna Late Phase Conference -
Late Phase Patient Reported Outcomes
November 4, 2009
Applied Clinical Trials October 2009 -
Late Phase Studies: An Early Priority
November 4, 2009
Next Generation Pharmaceutical, Q4 2009 -
Sound responses to the changing late-phase game
November 4, 2009
Next Generation Pharmaceutical, Q3 2009 -
Coordinating Safety Across Functions and Phases
November 3, 2009
A customer faced significant challenges with clinical and post-marketing safety. Without previous drug safety experience, they needed an ally who could provide a full range of safety and risk management solutions.